HEATHER CHOUTEAU: Open Payments
NPI 1093240111 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 32 payments from 15 companies in 2025. Trend: 2023 $280 · 2024 $567 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $99 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Corium, LLC | 3 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Tris Pharma Inc | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: ARISTADA, INGREZZA, Auvelity, REXULTI, CAPLYTA, Azstarys, TRINTELLIX, Dyanavel XR.
Industry payments across KY — which companies pay providers there.
